Regulation of endothelin-converting enzyme 1 in nephrotic syndrome in rats

Nephron Exp Nephrol. 2003;94(4):e137-45. doi: 10.1159/000072497.

Abstract

Background: Nephrotic syndrome is characterized by severe proteinuria and sodium and water retention. Although endothelin (ET) 1 can cause natriuresis or antinatriuresis, the role played by ET-1 in proteinuria and in sodium retention due to nephrotic syndrome remains unclear.

Methods: We investigated the role played by the ET-1 system in sodium and water retention and in proteinuria in puromycin aminonucleoside induced nephrotic syndrome in rats using microdissected nephron segments, competitive polymerase chain reaction, and Western blot.

Results: The expression of prepro ET-1, ET-converting enzyme 1 (ECE-1), and ET A receptor mRNAs, but not ET B receptor mRNA, in the glomeruli was increased in rats with nephrotic syndrome. The cGMP generation in the glomeruli induced by atrial natriuretic peptide and ET-1 was decreased, whereas the ET-3-induced cGMP generation was increased in rats with nephrotic syndrome. ECE-1 mRNA expression was increased not only in the glomeruli, but also in the thick ascending limbs and collecting ducts. The protein expression of ECE-1 was increased in the membrane fraction of the cortex and in the outer and the inner medulla of nephrotic rats. Blockade of ET A and B receptors by bosentan did not inhibit the occurrence of nephrotic syndrome. However, the administration of bosentan increased the urinary sodium excretion.

Conclusion: These data suggest that an activated ET-1-ET A receptor pathway in glomeruli and/or an increased ECE-1 mRNA expression in distal segments may participate in sodium and water retention, but not in the occurrence of nephrotic syndrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aspartic Acid Endopeptidases / genetics
  • Aspartic Acid Endopeptidases / metabolism
  • Aspartic Acid Endopeptidases / physiology*
  • Atrial Natriuretic Factor / metabolism
  • Bosentan
  • Cyclic GMP / biosynthesis
  • Endothelin Receptor Antagonists
  • Endothelin-1 / biosynthesis
  • Endothelin-1 / genetics
  • Endothelin-1 / metabolism
  • Endothelin-3 / metabolism
  • Endothelin-Converting Enzymes
  • Enzyme Induction / genetics
  • Gene Expression Regulation, Enzymologic / genetics
  • Kidney Glomerulus / enzymology
  • Male
  • Metalloendopeptidases / genetics
  • Metalloendopeptidases / metabolism
  • Metalloendopeptidases / physiology*
  • Nephrons / enzymology
  • Nephrons / metabolism
  • Nephrons / pathology
  • Nephrotic Syndrome / blood
  • Nephrotic Syndrome / enzymology*
  • Nephrotic Syndrome / metabolism
  • Nephrotic Syndrome / urine
  • Proteinuria / chemically induced
  • Puromycin Aminonucleoside / adverse effects
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Sulfonamides / pharmacology
  • Time Factors

Substances

  • Endothelin Receptor Antagonists
  • Endothelin-1
  • Endothelin-3
  • RNA, Messenger
  • Sulfonamides
  • Puromycin Aminonucleoside
  • Atrial Natriuretic Factor
  • Aspartic Acid Endopeptidases
  • Metalloendopeptidases
  • Endothelin-Converting Enzymes
  • Cyclic GMP
  • Bosentan